1.0Pharmacology/pharmBradley Olson/pharm/author/bradley-olson/Channing Der, PhD | Pharmacologyrich600338<blockquote class="wp-embedded-content" data-secret="Pxoke5f6IO"><a href="/pharm/directory/channing-der-phd/">Channing Der, PhD</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="/pharm/directory/channing-der-phd/embed/#?secret=Pxoke5f6IO" width="600" height="338" title="“Channing Der, PhD” — Pharmacology" data-secret="Pxoke5f6IO" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); /* ]]> */ </script> /pharm/wp-content/uploads/sites/930/2018/11/der.jpg130150Research Interests Ras oncogenes Rho family small GTPases protein kinases signal transduction target-based anti-cancer drug discovery Research Synopsis The broad goal of our research is to delineate the molecular basis of cancer to identify novel approaches for cancer treatment. One major focus of our studies is the study of the Ras oncoproteins, which are key … Read more